Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,530
Total Claims
$1.8M
Drug Cost
376
Beneficiaries
$4,821
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+311%
Cost per patient vs peers
$4,821 vs $1,174 avg
+102%
Brand preference vs peers
17.9% vs 8.9% avg
Brand vs Generic
Brand: 2,579 claims · $1.5M
Generic: 11,847 claims · $263K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 432 | $311K |
| Dulaglutide | 258 | $285K |
| Sitagliptin Phosphate | 258 | $169K |
| Empagliflozin | 224 | $155K |
| Fluticasone/Umeclidin/Vilanter | 109 | $76K |
| Linaclotide | 120 | $69K |
| Mirabegron | 123 | $61K |
| Icosapent Ethyl | 141 | $59K |
| Insulin Glargine,hum.Rec.Anlog | 111 | $54K |
| Apixaban | 70 | $44K |
| Icosapent Ethyl | 116 | $42K |
| Ticagrelor | 70 | $31K |
| Sacubitril/Valsartan | 34 | $24K |
| Diclofenac Sodium | 417 | $24K |
| Rivaroxaban | 32 | $23K |
Prescribing Profile
Patient Profile
69
Avg Age
61%
Female
1.38
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data